(RDVT) Red Violet - Overview
Stock: Identity Intelligence, Investigative Solution, Risk Mitigation, App-Based Tool
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.6% |
| Relative Tail Risk | -13.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.18 |
| Alpha | -12.86 |
| Character TTM | |
|---|---|
| Beta | 0.937 |
| Beta Downside | 0.922 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.20% |
| CAGR/Max DD | 0.70 |
Description: RDVT Red Violet December 25, 2025
Red Violet Inc. (NASDAQ: RDVT) is an analytics and information-solutions firm that builds proprietary identity-intelligence technology for U.S. customers. Its flagship platform, idiCORE, supports due-diligence, risk mitigation, identity authentication, fraud detection, customer acquisition, and regulatory compliance, while the FOREWARN app delivers real-time risk insights before face-to-face interactions.
The company’s addressable market spans financial services, insurance, healthcare, retail, telecom, law-enforcement, and corporate security, and it reaches these segments through a mix of value-added distributors, resellers, strategic partners, and direct sales channels. The global identity-verification market is projected to exceed $10 billion by 2028, growing at roughly a 12% compound annual rate, driven by tightening KYC/AML regulations and rising digital fraud.
According to its most recent 10-K, RDVT generated $13.2 million in revenue for FY 2023, a 28% year-over-year increase, and maintains gross margins near 70%, reflecting the high-value, software-centric nature of its offerings. The firm’s cash burn remains modest relative to its cash runway, but continued scaling will depend on expanding its partner ecosystem and capturing a larger share of the growing fraud-prevention spend. For a deeper dive into RDVT’s valuation multiples and risk profile, check out ValueRay’s latest report.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 11.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 9.02 > 1.0 |
| NWC/Revenue: 59.12% < 20% (prev 58.46%; Δ 0.67% < -1%) |
| CFO/TA 0.26 > 3% & CFO 29.4m > Net Income 11.2m |
| Net Debt (-42.5m) to EBITDA (20.4m): -2.08 < 3 |
| Current Ratio: 8.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (14.6m) vs 12m ago 2.15% < -2% |
| Gross Margin: 80.44% > 18% (prev 0.80%; Δ 7964 % > 0.5%) |
| Asset Turnover: 82.29% > 50% (prev 72.15%; Δ 10.14% > 0%) |
| Interest Coverage Ratio: -18.69 > 6 (EBITDA TTM 20.4m / Interest Expense TTM -676.0k) |
Altman Z'' 5.04
| A: 0.46 (Total Current Assets 58.0m - Total Current Liabilities 6.91m) / Total Assets 112.1m |
| B: 0.08 (Retained Earnings 9.47m / Total Assets 112.1m) |
| C: 0.12 (EBIT TTM 12.6m / Avg Total Assets 105.0m) |
| D: 0.92 (Book Value of Equity 9.48m / Total Liabilities 10.3m) |
| Altman-Z'' Score: 5.04 = AAA |
Beneish M -3.09
| DSRI: 1.01 (Receivables 10.4m/8.46m, Revenue 86.4m/70.7m) |
| GMI: 1.00 (GM 80.44% / 80.39%) |
| AQI: 0.89 (AQ_t 0.45 / AQ_t-1 0.50) |
| SGI: 1.22 (Revenue 86.4m / 70.7m) |
| TATA: -0.16 (NI 11.2m - CFO 29.4m) / TA 112.1m) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of RDVT shares?
Over the past week, the price has changed by -10.33%, over one month by -22.22%, over three months by -31.37% and over the past year by +2.10%.
Is RDVT a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RDVT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.5 | 68% |
| Analysts Target Price | 68.5 | 68% |
| ValueRay Target Price | 40.3 | -1.2% |
RDVT Fundamental Data Overview February 03, 2026
P/S = 7.3556
P/B = 6.2982
Revenue TTM = 86.4m USD
EBIT TTM = 12.6m USD
EBITDA TTM = 20.4m USD
Long Term Debt = 2.86m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 403.0k USD (from shortTermDebt, last quarter)
Debt = 2.86m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -42.5m USD (from netDebt column, last quarter)
Enterprise Value = 593.2m USD (635.7m + Debt 2.86m - CCE 45.4m)
Interest Coverage Ratio = -18.69 (Ebit TTM 12.6m / Interest Expense TTM -676.0k)
EV/FCF = 24.80x (Enterprise Value 593.2m / FCF TTM 23.9m)
FCF Yield = 4.03% (FCF TTM 23.9m / Enterprise Value 593.2m)
FCF Margin = 27.68% (FCF TTM 23.9m / Revenue TTM 86.4m)
Net Margin = 12.96% (Net Income TTM 11.2m / Revenue TTM 86.4m)
Gross Margin = 80.44% ((Revenue TTM 86.4m - Cost of Revenue TTM 16.9m) / Revenue TTM)
Gross Margin QoQ = 84.31% (prev 71.76%)
Tobins Q-Ratio = 5.29 (Enterprise Value 593.2m / Total Assets 112.1m)
Interest Expense / Debt = 9.99% (Interest Expense 286.0k / Debt 2.86m)
Taxrate = 15.09% (749.0k / 4.96m)
NOPAT = 10.7m (EBIT 12.6m * (1 - 15.09%))
Current Ratio = 8.39 (Total Current Assets 58.0m / Total Current Liabilities 6.91m)
Debt / Equity = 0.03 (Debt 2.86m / totalStockholderEquity, last quarter 101.7m)
Debt / EBITDA = -2.08 (Net Debt -42.5m / EBITDA 20.4m)
Debt / FCF = -1.78 (Net Debt -42.5m / FCF TTM 23.9m)
Total Stockholder Equity = 94.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.67% (Net Income 11.2m / Total Assets 112.1m)
RoE = 11.90% (Net Income TTM 11.2m / Total Stockholder Equity 94.1m)
RoCE = 13.03% (EBIT 12.6m / Capital Employed (Equity 94.1m + L.T.Debt 2.86m))
RoIC = 11.40% (NOPAT 10.7m / Invested Capital 94.1m)
WACC = 9.37% (E(635.7m)/V(638.6m) * Re(9.37%) + D(2.86m)/V(638.6m) * Rd(9.99%) * (1-Tc(0.15)))
Discount Rate = 9.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.24%
[DCF Debug] Terminal Value 76.95% ; FCFF base≈19.2m ; Y1≈23.7m ; Y5≈40.3m
Fair Price DCF = 41.16 (EV 532.6m - Net Debt -42.5m = Equity 575.1m / Shares 14.0m; r=9.37% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 29.08 | EPS CAGR: -2.07% | SUE: -2.03 | # QB: 0
Revenue Correlation: 97.23 | Revenue CAGR: 21.10% | SUE: 0.71 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.28 | Chg30d=+0.105 | Revisions Net=+2 | Growth EPS=+10.8% | Growth Revenue=+14.3%